Cargando…
Can SARS‐CoV‐2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review
INTRODUCTION: Although the COVID‐19 vaccination is deemed safe, exact incidence and nature if adverse effects, particularly dermatological ones, are still unknown. OBJECTIVE: To describe the demographic, clinical, morphological characteristics, outcomes, and timing of development of herpes zoster to...
Autores principales: | Desai, Hardik D., Sharma, Kamal, Shah, Anchal, Patoliya, Jaimini, Patil, Anant, Hooshanginezhad, Zahra, Grabbe, Stephan, Goldust, Mohamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597588/ https://www.ncbi.nlm.nih.gov/pubmed/34719084 http://dx.doi.org/10.1111/jocd.14521 |
Ejemplares similares
-
A Rare Case of Varicella-Zoster Virus Reactivation Following Recovery From COVID-19
por: Desai, Hardik D, et al.
Publicado: (2021) -
Takotsubo Syndrome a Rare Entity in COVID-19: a Systemic Review—Focus on Biomarkers, Imaging, Treatment, and Outcome
por: Sharma, Kamal, et al.
Publicado: (2021) -
Potential risk factors for Varicella‐zoster virus reactivation after COVID‐19 vaccination
por: May Lee, Marco, et al.
Publicado: (2022) -
Herpes zoster: A Review of Clinical Manifestations and Management
por: Patil, Anant, et al.
Publicado: (2022) -
Role of Self-Measured Home Blood Pressure Monitoring (HBPM) and Effectiveness of Telemedicine During the Era of COVID-19 Pandemic
por: Sharma, Kamal, et al.
Publicado: (2021)